HIV Health & Wellbeing

HIV and weight changes: why losing weight and gaining weight both deserve attention

If you are living with HIV and the number on the scale has moved without you trying, that change is information worth acting on — in either direction.

Weight is one of the most confusing parts of living with HIV, partly because the story has genuinely reversed within a single generation. For most of the epidemic's history, weight loss was the feared outcome. Today, the more common conversation in clinic is about weight gain. Both are real, both are still happening, and neither is a personal failing.

This article explains what's behind each, why unintentional weight loss is a signal you should never manage on your own, and how body changes affect the part of life nobody puts in a pamphlet — confidence, self-image, and dating.

Unintentional weight loss: still a warning sign

In the years before effective treatment, wasting was one of the defining features of advanced HIV. It was an AIDS-defining condition, and it affected close to a third of people with HIV during that period. Combination antiretroviral therapy changed that dramatically — severe wasting became far less common once effective regimens were widely available.

What surprises people is that it did not disappear. One large US analysis covering 2012 to 2018 found a cumulative prevalence of HIV-associated wasting of roughly 18 percent, with a striking gap by insurance type: about 7.5 percent among people with commercial or Medicare Supplemental coverage compared with about 23.5 percent among people covered by Medicaid. That gap says something about access and social circumstances, not about biology.

The clinical picture has also shifted. Unintentional weight loss now occurs largely in people whose virus is suppressed, which is why an expert panel proposed an updated term in 2024 — HIV-associated weight loss — separate from the older wasting definition built around advanced disease. The traditional definition involved losing more than 10 percent of body weight along with fever plus weakness or diarrhea lasting at least a month.

Why smaller losses still matter

You do not need to hit the 10 percent threshold for weight loss to be clinically meaningful. Research across multiple cohorts has linked losses of around 5 percent over a period of months to worse outcomes, and losses of 10 percent or more have been associated with a several-fold increase in mortality risk even among people receiving treatment. That's precisely why clinicians treat an unexplained downward trend as a reason to investigate rather than reassure.

Possible contributors are wide-ranging — opportunistic infections, gastrointestinal problems, medication side effects, depression, food insecurity, substance use, and aging-related conditions among them. Sorting through that list is a job for your care team, and it usually starts with labs and a conversation rather than a diet.

The other direction: weight gain on modern treatment

Over the past decade the dominant weight conversation in HIV care has flipped. Regimens built on integrase strand transfer inhibitors — the drug class including dolutegravir and bictegravir — have been consistently associated with more weight gain than older classes.

In a large North American cohort study, people starting treatment on an integrase-inhibitor regimen had meaningfully higher odds of gaining more than 10 percent of body weight within two years compared with those starting an NNRTI-based regimen. Women and people with lower CD4 counts at baseline were among those at higher odds. Other cohorts have found more modest average changes, so the effect is real but uneven — some people gain very little, and a subset gain a clinically significant amount.

Two nuances are worth holding onto, because they change how the news lands:

• Some gain is recovery. Weight increase after starting treatment partly reflects the body returning to health as viral replication is controlled. Gaining back weight you lost while untreated is not the same problem as gaining beyond a healthy range.
• What you stopped matters as much as what you started. Analysis of people switching to newer integrase-inhibitor regimens found that those coming off efavirenz- or tenofovir disoproxil–containing regimens had higher odds of gaining weight — raising the possibility that some of the effect reflects the loss of a weight-suppressing drug rather than a new drug driving gain.

None of this is a reason to stop or switch a regimen on your own initiative. Viral suppression is the priority, and any regimen change is a decision to make with your HIV provider, weighing metabolic effects against everything else the regimen is doing for you.

Body shape changes are a separate issue

Lipodystrophy — fat loss in the face, arms, and legs, sometimes with accumulation around the abdomen or upper back — is often lumped in with weight, but it's distinct. It's associated primarily with older antiretroviral drugs, and reported rates in the literature vary enormously depending on how studies defined and measured it, with fat loss specifically affecting a smaller subset.

For long-term survivors who were treated in earlier eras, these changes can be permanent and highly visible, which is a very different experience from a number moving on a scale. If this is your situation, it's worth asking your provider what's available — this is an area where options exist and where you shouldn't assume nothing can be done.

The part that doesn't show up in the clinical literature

Body changes affect how people see themselves, and that spills directly into whether they feel able to date, be photographed, be touched, or be seen. That effect is documented, and among people living with HIV it stacks on top of the disclosure anxiety that's already there. The result is often quiet withdrawal — declining plans, not updating photos, deciding privately that this part of life is over for now.

It's worth naming the loop: withdrawing socially tends to make body-image distress worse rather than better, and isolation is itself associated with poorer health engagement. Staying connected is not a luxury item you earn once you feel good about how you look.

Two things genuinely help. The first is bringing the physical change to your care team rather than sitting with it — because unintentional weight loss in particular may be treatable, and because feeling powerless is a large part of what makes it hard.

The second is talking to people who have been through it. There's a difference between reassurance from someone who has never faced this and a straight answer from someone who has been on the same regimen, watched their body change, and dated anyway.

Practical questions worth bringing to your next appointment

• Has my weight trend changed since my last visit, and by how much?
• Could anything in my current regimen be contributing, in either direction?
• Are there tests that would help explain an unintentional change?
• Should I be screened for metabolic or cardiovascular risk factors?
• If I want to change my weight intentionally, what's safe given my treatment and health status?

That last one matters. Intentional weight management is not off-limits for people with HIV, but it should be planned with a clinician who knows your regimen, your labs, and your history — not assembled from general-audience diet advice.